Inqovi Tablets, FDA Approved for Treatment of MDS and CMML, Available at Biologics by McKesson
August 24th 2020Inqovi was approved by the FDA on July 7, 2020, for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML).
Read More